1. Home
  2. CMPS vs ABSI Comparison

CMPS vs ABSI Comparison

Compare CMPS & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo COMPASS Pathways Plc American Depository Shares

CMPS

COMPASS Pathways Plc American Depository Shares

HOLD

Current Price

$6.85

Market Cap

611.6M

Sector

Health Care

ML Signal

HOLD

Logo Absci Corporation

ABSI

Absci Corporation

HOLD

Current Price

$3.58

Market Cap

577.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMPS
ABSI
Founded
2020
2011
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
611.6M
577.4M
IPO Year
2020
2021

Fundamental Metrics

Financial Performance
Metric
CMPS
ABSI
Price
$6.85
$3.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
6
Target Price
$16.43
$7.98
AVG Volume (30 Days)
1.4M
3.9M
Earning Date
11-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$2,815,000.00
Revenue This Year
N/A
$10.72
Revenue Next Year
N/A
$437.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.25
$2.01
52 Week High
$7.15
$6.33

Technical Indicators

Market Signals
Indicator
CMPS
ABSI
Relative Strength Index (RSI) 62.97 52.82
Support Level $6.08 $3.37
Resistance Level $7.15 $3.79
Average True Range (ATR) 0.41 0.26
MACD 0.07 0.01
Stochastic Oscillator 80.45 32.39

Price Performance

Historical Comparison
CMPS
ABSI

About CMPS COMPASS Pathways Plc American Depository Shares

Compass Pathways PLC is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company is motivated by the need to find ways to help and empower people suffering with mental health challenges who are not helped by existing therapies and are pioneering the development of a new model of psilocybin therapy, in which psilocybin is administered in conjunction with psychological support. Its focus is on treatment-resistant depression, or TRD, a subset of major depressive disorder, or MDD, comprising patients who are inadequately served by the treatment paradigm. It has developed a proprietary, high-purity polymorphic crystalline formulation of psilocybin, COMP360.

About ABSI Absci Corporation

Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

Share on Social Networks: